Price T Rowe Associates Inc Avidity Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 10,916,626 shares of RNA stock, worth $516 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

10,916,626

Previous 7,429,107 46.94%

Holding current value

$516 Million

Previous $190 Million 135.21%

% of portfolio

0.05%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $79.3 Million - $142 Million	3,487,519 Added 46.94%	10,916,626 $446 Million
Q1 2024 May 15, 2024	BUY	$9.16 - $25.52 $4.73 Million - $13.2 Million	516,446 Added 7.47%	7,429,107 $190 Million
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $1.44 Million - $2.78 Million	296,238 Added 4.48%	6,912,661 $62.6 Million
Q3 2023 Nov 14, 2023	SELL	$6.3 - $11.35 $427,253 - $769,734	-67,818 Reduced 1.01%	6,616,423 $42.2 Million
Q2 2023 Aug 14, 2023	SELL	$10.62 - $17.34 $1.91 Million - $3.12 Million	-180,144 Reduced 2.62%	6,684,241 $74.1 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $2.41 Million - $4.03 Million	157,098 Added 2.34%	6,864,385 $105 Million
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $15.5 Million - $34.9 Million	1,538,264 Added 29.76%	6,707,287 $149 Million
Q3 2022 Nov 14, 2022	SELL	$15.46 - $23.43 $42 Million - $63.6 Million	-2,714,102 Reduced 34.43%	5,169,023 $84.4 Million
Q2 2022 Aug 15, 2022	SELL	$11.18 - $20.5 $1.14 Million - $2.1 Million	-102,410 Reduced 1.28%	7,883,125 $115 Million
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $3.6 Million - $6.03 Million	253,689 Added 3.28%	7,985,535 $147 Million
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $13.1 Million - $18.4 Million	641,196 Added 9.04%	7,731,846 $184 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $82.7 Million - $115 Million	4,553,579 Added 179.48%	7,090,650 $175 Million
Q2 2021 Aug 16, 2021	BUY	$19.62 - $29.26 $15.3 Million - $22.8 Million	779,336 Added 44.34%	2,537,071 $62.7 Million
Q1 2021 May 17, 2021	BUY	$20.28 - $28.15 $16.5 Million - $22.9 Million	812,897 Added 86.04%	1,757,735 $38.3 Million
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $23.4 Million - $33.2 Million	944,838 New	944,838 $24.1 Million

Others Institutions Holding RNA

# of Institutions

219

Shares Held

95.9M

Call Options Held

171K

Put Options Held

196K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.46B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Avidity Biosciences, Inc. Transaction History